Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Back to Top

New Insights into Immunotherapy for Allergic Disorders

G. Walter Canonica
G. Walter Canonica, MD

Roy Gerth van Wijk

Dear Colleagues,

Welcome to the 34th symposium of the World Allergy Forum, ”The Future Use of Biologicals in Allergy and Asthma”. World Allergy Forum is the longest running educational program of the World Allergy Organization, and it is a great pleasure to bring the latest symposium in this series to the 2009 EAACI Congress in Warsaw.

We are all hoping for new developments in the therapeutic armamentarium for asthma and other allergic diseases, and particularly for therapies to address the increasingly severe and complex allergic symptomatology that we are seeing in our clinics. Today’s symposium will start with reviews on the future use of biological therapies in allergy and asthma. In his presentation, Future Use of Biologicals in Allergy and Asthma – Pro, Andrew Wardlaw will discuss the anticipated uses and benefits of this type of therapy; then Klaus Rabe, speaking on Future Use of Biologicals in Allergy and Asthma - Con, will consider some of the negative aspects. Anti-IgE is the only biological agent currently authorised and available globally for patients with allergic asthma, and our presentations will conclude with William Busse’s presentation Anti-IgE – Beyond the Current Indications; offering insights into a number of IgE-dependent processes which may benefit from this therapy. We look forward to concluding the symposium with discussion on these exciting presentations!

With best regards,

G. Walter Canonica, MD FAAAAI
World Allergy Organization

Roy Gerth van Wijk
European Academy of Allergology and Clinical Immunology

Return to top

Return to WAF: Warsaw, Poland index